These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24698184)

  • 1. Teratogenic mechanisms associated with prenatal medication exposure.
    van Gelder MM; van Rooij IA; de Jong-van den Berg LT; Roeleveld N
    Therapie; 2014; 69(1):13-24. PubMed ID: 24698184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratogenic mechanisms of medical drugs.
    van Gelder MM; van Rooij IA; Miller RK; Zielhuis GA; de Jong-van den Berg LT; Roeleveld N
    Hum Reprod Update; 2010; 16(4):378-94. PubMed ID: 20061329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provision of potentially teratogenic medications to female veterans of childbearing age.
    Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB
    Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of reproductive life plans in identification of potentially teratogenic medication use: A pilot study.
    DiPietro Mager N; Mills C; Snelling A
    Birth; 2018 Mar; 45(1):50-54. PubMed ID: 29052257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
    Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor- and reactive intermediate-mediated mechanisms of teratogenesis.
    Wells PG; Lee CJ; McCallum GP; Perstin J; Harper PA
    Handb Exp Pharmacol; 2010; (196):131-62. PubMed ID: 20020262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress as a mechanism of teratogenesis.
    Hansen JM
    Birth Defects Res C Embryo Today; 2006 Dec; 78(4):293-307. PubMed ID: 17315243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common teratogenic medication exposures-a population-based study of pregnancies in the United States.
    Wang Y; Smolinski NE; Thai TN; Sarayani A; Ewig C; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol MFM; 2024 Jan; 6(1):101245. PubMed ID: 38061552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic susceptibility to teratogens: state of the art.
    Cassina M; Salviati L; Di Gianantonio E; Clementi M
    Reprod Toxicol; 2012 Sep; 34(2):186-91. PubMed ID: 22659091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of teratogenic medications in United States ambulatory practices.
    Schwarz EB; Maselli J; Norton M; Gonzales R
    Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal effects on ethanol teratogenesis in a cross between A/J and C57BL/6J mice.
    Gilliam D; Valdez N; Branson S; Dixon A; Downing C
    Alcohol; 2011 Aug; 45(5):441-9. PubMed ID: 21641750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox control of teratogenesis.
    Hansen JM; Harris C
    Reprod Toxicol; 2013 Jan; 35():165-79. PubMed ID: 23089153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of drug-induced birth defects: what is known so far?
    Wilffert B; Altena J; Tijink L; van Gelder MM; de Jong-van den Berg LT
    Pharmacogenomics; 2011 Apr; 12(4):547-58. PubMed ID: 21521026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
    Cassina M; Cagnoli GA; Zuccarello D; Di Gianantonio E; Clementi M
    Eur J Med Genet; 2017 Jan; 60(1):22-31. PubMed ID: 27639441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian hierarchical methods in the detection of potentially teratogenic first-trimester medications.
    Cavadino A; Prieto-Merino D; Morris JK
    Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):337-346. PubMed ID: 31908100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research challenges for drug-induced birth defects.
    Mitchell AA
    Clin Pharmacol Ther; 2016 Jul; 100(1):26-8. PubMed ID: 27037730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on new developments in the study of human teratogens.
    Shepard TH; Brent RL; Friedman JM; Jones KL; Miller RK; Moore CA; Polifka JE
    Teratology; 2002 Apr; 65(4):153-61. PubMed ID: 11948561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's perspectives on counseling about risks for medication-induced birth defects.
    Santucci AK; Gold MA; Akers AY; Borrero S; Schwarz EB
    Birth Defects Res A Clin Mol Teratol; 2010 Jan; 88(1):64-9. PubMed ID: 19637252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic toxicities of human teratogens.
    Bishop JB; Witt KL; Sloane RA
    Mutat Res; 1997 Dec; 396(1-2):9-43. PubMed ID: 9434858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.